A transcription factor active on the epidermal growth factor receptor gene
- PMID: 3393529
- PMCID: PMC281678
- DOI: 10.1073/pnas.85.14.5016
A transcription factor active on the epidermal growth factor receptor gene
Abstract
We have developed an in vitro transcription system for the epidermal growth factor receptor (EGFR) oncogene by using nuclear extracts of A431 human epidermoid carcinoma cells, which overproduce EGFR. We found that a nuclear factor, termed EGFR-specific transcription factor (ETF), specifically stimulated EGFR transcription by 5- to 10-fold. In this report, ETF, purified by using sequence-specific oligonucleotide affinity chromatography, is shown by renaturing material eluted from a NaDodSO4/polyacrylamide gel to be a protein with a molecular mass of 120 kDa. ETF binds to the promoter region, as measured by DNase I "footprinting" and gel-mobility-shift assays, and specifically stimulates the transcription of the EGFR gene in a reconstituted in vitro transcription system. These results suggest that ETF could play a role in the overexpression of the cellular oncogene EGFR.
Similar articles
-
Epidermal growth factor (EGF) receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor.J Biol Chem. 1988 May 5;263(13):6329-36. J Biol Chem. 1988. PMID: 3283124
-
Nuclear factor ETF specifically stimulates transcription from promoters without a TATA box.J Biol Chem. 1989 Sep 15;264(26):15508-14. J Biol Chem. 1989. PMID: 2768275
-
Purification and characterization of chicken ovalbumin gene upstream promoter transcription factor from homologous oviduct cells.Mol Cell Biol. 1987 Dec;7(12):4151-8. doi: 10.1128/mcb.7.12.4151-4158.1987. Mol Cell Biol. 1987. PMID: 3437886 Free PMC article.
-
The role of carbohydrate as a post-translational modification of the receptor for epidermal growth factor.Adv Exp Med Biol. 1988;231:569-82. doi: 10.1007/978-1-4684-9042-8_48. Adv Exp Med Biol. 1988. PMID: 3046253 Review. No abstract available.
-
Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.Br Med Bull. 1991 Jan;47(1):87-98. doi: 10.1093/oxfordjournals.bmb.a072464. Br Med Bull. 1991. PMID: 1863851 Review.
Cited by
-
ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma.Onco (Basel). 2022 Dec;2(4):282-304. doi: 10.3390/onco2040016. Epub 2022 Oct 14. Onco (Basel). 2022. PMID: 36311273 Free PMC article.
-
Compilation of vertebrate-encoded transcription factors.Nucleic Acids Res. 1992 Jan 11;20(1):3-26. doi: 10.1093/nar/20.1.3. Nucleic Acids Res. 1992. PMID: 1738600 Free PMC article. No abstract available.
-
Characterization of the promoter region of the human c-kit proto-oncogene.Jpn J Cancer Res. 1993 Nov;84(11):1136-44. doi: 10.1111/j.1349-7006.1993.tb02813.x. Jpn J Cancer Res. 1993. PMID: 7506248 Free PMC article.
-
Upregulated Expression of ErbB1 in Diffuse Large B-Cell Lymphoma as a Predictor of Poor Overall Survival Outcome.J Pers Med. 2023 Apr 29;13(5):770. doi: 10.3390/jpm13050770. J Pers Med. 2023. PMID: 37240940 Free PMC article.
-
Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):153-63. doi: 10.1023/a:1026303814855. J Mammary Gland Biol Neoplasia. 1997. PMID: 10882301 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous